<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:fd4b2a43-332f-4e22-b96d-35c622fecade,g:fa7f32d9-b55a-4573-94cd-dfb21ad90913-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0a4a266d-850d-4449-9d5a-b0a6daccc8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1d95fc0b-3e2f-4e8d-9c8b-a680583ac277" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0a4a266d-850d-4449-9d5a-b0a6daccc8a7" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1d95fc0b-3e2f-4e8d-9c8b-a680583ac277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_aa0fc85a-d762-495d-88f1-5eca714aac0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0a4a266d-850d-4449-9d5a-b0a6daccc8a7" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_aa0fc85a-d762-495d-88f1-5eca714aac0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_50d5c8ac-9cd5-4952-b89d-b9010d1b9d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0a4a266d-850d-4449-9d5a-b0a6daccc8a7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_50d5c8ac-9cd5-4952-b89d-b9010d1b9d8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_745d5c0a-024c-4a18-bc22-16aa1f49958b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cc831350-35a1-426f-b0a1-ae921a2e25aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_745d5c0a-024c-4a18-bc22-16aa1f49958b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_cc831350-35a1-426f-b0a1-ae921a2e25aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e9d5c368-7ad7-4601-aa80-d2572b2b8afc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_745d5c0a-024c-4a18-bc22-16aa1f49958b" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e9d5c368-7ad7-4601-aa80-d2572b2b8afc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b5425f4-b7ea-4976-9137-3a82d1ce157e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0b2cbd4f-97ca-4f5a-9563-e99cfb427519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b5425f4-b7ea-4976-9137-3a82d1ce157e" xlink:to="loc_us-gaap_OperatingIncomeLoss_0b2cbd4f-97ca-4f5a-9563-e99cfb427519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_cfdb98dd-8b1f-41d2-8621-86c9994e51f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b5425f4-b7ea-4976-9137-3a82d1ce157e" xlink:to="loc_us-gaap_InterestExpenseNonoperating_cfdb98dd-8b1f-41d2-8621-86c9994e51f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNet_42984731-5b45-4ff6-b433-b60d3e370658" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b5425f4-b7ea-4976-9137-3a82d1ce157e" xlink:to="loc_us-gaap_InvestmentIncomeNet_42984731-5b45-4ff6-b433-b60d3e370658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bde1e103-9a36-4d77-b656-40e6f612c8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_8b5425f4-b7ea-4976-9137-3a82d1ce157e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bde1e103-9a36-4d77-b656-40e6f612c8c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_58477f38-a52b-480c-af3e-7ac2496d08d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d2517fe0-6b01-46bc-94ce-d2a5525f1c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_58477f38-a52b-480c-af3e-7ac2496d08d1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d2517fe0-6b01-46bc-94ce-d2a5525f1c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_10839078-ca21-40ce-bc95-9dc9abeb0ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_58477f38-a52b-480c-af3e-7ac2496d08d1" xlink:to="loc_us-gaap_GrossProfit_10839078-ca21-40ce-bc95-9dc9abeb0ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ac732cee-ddbd-4dcf-8912-b809e334d399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_58477f38-a52b-480c-af3e-7ac2496d08d1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ac732cee-ddbd-4dcf-8912-b809e334d399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_2919d70b-d3fa-4a19-9d98-43a58180787a" xlink:href="wst-20250331.xsd#wst_OtherIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_58477f38-a52b-480c-af3e-7ac2496d08d1" xlink:to="loc_wst_OtherIncomeExpense_2919d70b-d3fa-4a19-9d98-43a58180787a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="wst-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_777d8a28-2b52-48b4-a4c5-4e51683b3d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38c7bc93-52ed-49dc-99bc-31644f48a4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_777d8a28-2b52-48b4-a4c5-4e51683b3d7c" xlink:to="loc_us-gaap_NetIncomeLoss_38c7bc93-52ed-49dc-99bc-31644f48a4c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7fa350ea-b872-43e5-9585-8906289a9f46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_777d8a28-2b52-48b4-a4c5-4e51683b3d7c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7fa350ea-b872-43e5-9585-8906289a9f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f805430-b768-403c-91c3-e563167e7a45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_66c15be1-73e8-464d-babf-954102ebd89e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f805430-b768-403c-91c3-e563167e7a45" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_66c15be1-73e8-464d-babf-954102ebd89e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent_575becac-4406-46f1-861d-a73f617edc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciEquityMethodInvestmentAfterTaxParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f805430-b768-403c-91c3-e563167e7a45" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTaxParent_575becac-4406-46f1-861d-a73f617edc4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_74b28997-c287-4423-9655-bc2a6a7f0f81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f805430-b768-403c-91c3-e563167e7a45" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_74b28997-c287-4423-9655-bc2a6a7f0f81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_6f049fd1-d70e-450c-89e0-46afa2809877" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2f805430-b768-403c-91c3-e563167e7a45" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax_6f049fd1-d70e-450c-89e0-46afa2809877" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="wst-20250331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_3b32aa0f-97fc-4ae3-9df1-7bc292579f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_LiabilitiesCurrent_3b32aa0f-97fc-4ae3-9df1-7bc292579f8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_400b2f49-ec61-474d-b3f8-5f44f1720a99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_400b2f49-ec61-474d-b3f8-5f44f1720a99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ceaa55a1-c288-4bea-85dc-155733935211" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ceaa55a1-c288-4bea-85dc-155733935211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_15fcee9d-363f-43f0-aa44-e52e046fe8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_15fcee9d-363f-43f0-aa44-e52e046fe8b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_07c40334-d876-4874-8afd-9e8c021ac505" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_07c40334-d876-4874-8afd-9e8c021ac505" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ba056333-4278-4e09-a313-85d81f3ebf83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ba056333-4278-4e09-a313-85d81f3ebf83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3d390f46-9705-4a2d-a30b-adcc1513b47c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_5b2c07c5-dc2b-4f6b-ae50-08a7d9fe261f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3d390f46-9705-4a2d-a30b-adcc1513b47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3e880b72-b86d-4b99-891d-b2b622238899" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_19e66758-ba00-4d49-ad0c-eee368e1cc2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3e880b72-b86d-4b99-891d-b2b622238899" xlink:to="loc_us-gaap_Liabilities_19e66758-ba00-4d49-ad0c-eee368e1cc2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_64c1b909-128f-42fd-bc3f-7719c0796a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3e880b72-b86d-4b99-891d-b2b622238899" xlink:to="loc_us-gaap_CommitmentsAndContingencies_64c1b909-128f-42fd-bc3f-7719c0796a1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_472b7ceb-edcc-44aa-a5d8-2d14d217462a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_3e880b72-b86d-4b99-891d-b2b622238899" xlink:to="loc_us-gaap_StockholdersEquity_472b7ceb-edcc-44aa-a5d8-2d14d217462a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f681d763-60cb-4b1f-926c-6cca82c09fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fec2ae53-8c15-4061-afe9-518db6e5b8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f681d763-60cb-4b1f-926c-6cca82c09fd5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fec2ae53-8c15-4061-afe9-518db6e5b8ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dc699146-8509-4557-a9ee-b6fccfed3dea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f681d763-60cb-4b1f-926c-6cca82c09fd5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dc699146-8509-4557-a9ee-b6fccfed3dea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_afbc0863-13ea-4603-a59a-1a38ece9d89d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f681d763-60cb-4b1f-926c-6cca82c09fd5" xlink:to="loc_us-gaap_InventoryNet_afbc0863-13ea-4603-a59a-1a38ece9d89d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_29233073-7f03-4146-9e9f-26206889e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f681d763-60cb-4b1f-926c-6cca82c09fd5" xlink:to="loc_us-gaap_OtherAssetsCurrent_29233073-7f03-4146-9e9f-26206889e59e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0ce89b7f-a780-424c-b65c-1171d690d848" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:to="loc_us-gaap_PreferredStockValue_0ce89b7f-a780-424c-b65c-1171d690d848" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_58d9b76f-f070-468d-973e-ec89d7f3aae2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:to="loc_us-gaap_CommonStockValue_58d9b76f-f070-468d-973e-ec89d7f3aae2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_6c251b18-2abd-4976-9416-6cb2257e7214" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:to="loc_us-gaap_AdditionalPaidInCapital_6c251b18-2abd-4976-9416-6cb2257e7214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8329fff1-7819-4036-9e55-33e78cf7c94f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8329fff1-7819-4036-9e55-33e78cf7c94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_870f85d7-e017-4a0e-bd87-b3d314b2395f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_870f85d7-e017-4a0e-bd87-b3d314b2395f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_ab22bc6c-4b96-49eb-845d-c73150c01ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_d25ef28e-9bdb-4331-bbc1-a14c6c3ad7ab" xlink:to="loc_us-gaap_TreasuryStockCommonValue_ab22bc6c-4b96-49eb-845d-c73150c01ef3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cc384a37-8aaa-4a94-9248-25f73644a6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_694979aa-6a33-4226-adff-9333ab473d08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cc384a37-8aaa-4a94-9248-25f73644a6d1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_694979aa-6a33-4226-adff-9333ab473d08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_401a2a00-9e03-4d3d-910b-278dd21aecf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_cc384a37-8aaa-4a94-9248-25f73644a6d1" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_401a2a00-9e03-4d3d-910b-278dd21aecf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1f459483-9d82-4909-b70e-8aec2df467c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d21e5ec1-8954-454f-a648-6498395373c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f459483-9d82-4909-b70e-8aec2df467c1" xlink:to="loc_us-gaap_AccountsPayableCurrent_d21e5ec1-8954-454f-a648-6498395373c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_6f46f6a9-3574-4583-95ad-793520990c94" xlink:href="wst-20250331.xsd#wst_AccruedSalariesWagesAndBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f459483-9d82-4909-b70e-8aec2df467c1" xlink:to="loc_wst_AccruedSalariesWagesAndBenefitsCurrent_6f46f6a9-3574-4583-95ad-793520990c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_84296a46-72a2-47c1-9f5e-4086f4414b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f459483-9d82-4909-b70e-8aec2df467c1" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_84296a46-72a2-47c1-9f5e-4086f4414b7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0cd7d9b0-4ced-40fb-9c15-10b39d713638" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f459483-9d82-4909-b70e-8aec2df467c1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0cd7d9b0-4ced-40fb-9c15-10b39d713638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_22e242a3-8c22-4f4f-8374-b0f4d1ebdf28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1f459483-9d82-4909-b70e-8aec2df467c1" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_22e242a3-8c22-4f4f-8374-b0f4d1ebdf28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f6b6e31f-f87c-43c6-86d8-d473984ece36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_AssetsCurrent_f6b6e31f-f87c-43c6-86d8-d473984ece36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7cb337a0-e1d2-4d08-aa51-a4a1d21eed66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7cb337a0-e1d2-4d08-aa51-a4a1d21eed66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3d61ab2f-9fb2-436e-b5ff-b2683eb5a7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3d61ab2f-9fb2-436e-b5ff-b2683eb5a7fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_94954e50-0883-4d3c-b65b-d7f9ac087fcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_94954e50-0883-4d3c-b65b-d7f9ac087fcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f7b21d35-52d2-43e2-9635-a9bd40e10d08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_Goodwill_f7b21d35-52d2-43e2-9635-a9bd40e10d08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e2fd1ec7-b609-42f1-84cf-f180f262086b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e2fd1ec7-b609-42f1-84cf-f180f262086b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c9697542-d7a8-4c01-b828-997518ba3094" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c9697542-d7a8-4c01-b828-997518ba3094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2684fefd-2e46-4edc-b17d-2b9c57fa941b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a348d301-6e5a-45d2-8cd0-0c45a96cf674" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2684fefd-2e46-4edc-b17d-2b9c57fa941b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="wst-20250331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_08fd20f4-6a65-417b-ace1-bc244c99e62d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_08fd20f4-6a65-417b-ace1-bc244c99e62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d7e3c2af-50bf-453f-acd0-108bddaef4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d7e3c2af-50bf-453f-acd0-108bddaef4b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1455581b-998b-441a-84f0-26ed9d4cee6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1455581b-998b-441a-84f0-26ed9d4cee6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_e11f18c0-ce0f-442f-9ed7-eae81dee613f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_e11f18c0-ce0f-442f-9ed7-eae81dee613f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_08dd57f5-8589-4e0b-9d2d-30db1f6ffb33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_08dd57f5-8589-4e0b-9d2d-30db1f6ffb33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5eed6b41-c05f-4bf8-bb0a-d77a8cca65d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_5eed6b41-c05f-4bf8-bb0a-d77a8cca65d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_a7f27235-3013-447e-b1ce-a851578dfac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d8e7b345-e7bb-407a-b3e2-cd2adc83fc74" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_a7f27235-3013-447e-b1ce-a851578dfac0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_901bf7f3-b632-4a94-8bb8-914faa8756c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d0292c5-cb36-414f-877a-73b95701496b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_901bf7f3-b632-4a94-8bb8-914faa8756c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d0292c5-cb36-414f-877a-73b95701496b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f0b1206-5ae5-4749-b906-4a076c8505eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_901bf7f3-b632-4a94-8bb8-914faa8756c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f0b1206-5ae5-4749-b906-4a076c8505eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4cb81eb-f1c5-4df3-8741-3b2e9cb49b58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_901bf7f3-b632-4a94-8bb8-914faa8756c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e4cb81eb-f1c5-4df3-8741-3b2e9cb49b58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4aafc90-a219-4999-8b9d-ad82ff7f37d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_901bf7f3-b632-4a94-8bb8-914faa8756c1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d4aafc90-a219-4999-8b9d-ad82ff7f37d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_930ec44a-2632-45c3-8832-db8faf7989f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8be754a8-ce4e-4477-a49a-44b063a2159b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_930ec44a-2632-45c3-8832-db8faf7989f0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8be754a8-ce4e-4477-a49a-44b063a2159b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_99f502b6-d9c7-4124-87b6-4121ad5db406" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_NetIncomeLoss_99f502b6-d9c7-4124-87b6-4121ad5db406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_886f3fbf-afe9-469d-b294-34c217a02fac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_Depreciation_886f3fbf-afe9-469d-b294-34c217a02fac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_32b0a22d-26d5-4f30-a0f0-284dc097cbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_AdjustmentForAmortization_32b0a22d-26d5-4f30-a0f0-284dc097cbcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_15637e3e-70ee-41f2-85fc-67f206da9e87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_ShareBasedCompensation_15637e3e-70ee-41f2-85fc-67f206da9e87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b95eee3a-fc40-41e1-a3fc-7e337c3bc4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_AssetImpairmentCharges_b95eee3a-fc40-41e1-a3fc-7e337c3bc4bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_bb3d6bb4-9a83-420f-a7f0-6d387df00517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_RestructuringCharges_bb3d6bb4-9a83-420f-a7f0-6d387df00517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cfbfea0b-3de9-4506-975a-3649b27f4983" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cfbfea0b-3de9-4506-975a-3649b27f4983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapital_3850c633-343e-43a6-b344-d795d16d3339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapital"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_045db4cf-e601-4499-933d-08c9b2d624ca" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapital_3850c633-343e-43a6-b344-d795d16d3339" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/NetIncomePerShareScheduleofNetIncomePerShareDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#NetIncomePerShareScheduleofNetIncomePerShareDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/NetIncomePerShareScheduleofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49f2dba5-7cc4-4728-a867-cee59d64a9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f5f846f-874b-453f-ac53-5a609067565b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49f2dba5-7cc4-4728-a867-cee59d64a9c4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6f5f846f-874b-453f-ac53-5a609067565b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c206a994-5ac8-45f8-8c87-f3520cef2e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_49f2dba5-7cc4-4728-a867-cee59d64a9c4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c206a994-5ac8-45f8-8c87-f3520cef2e5b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/InventoriesDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_29f1201e-3123-47e8-9cd7-64ff267d4381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9324ca96-5f2d-4abc-9126-30379b498411" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_29f1201e-3123-47e8-9cd7-64ff267d4381" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_9324ca96-5f2d-4abc-9126-30379b498411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eece3d0e-b35c-4b04-b7c8-a70406671bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_29f1201e-3123-47e8-9cd7-64ff267d4381" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eece3d0e-b35c-4b04-b7c8-a70406671bd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4f666670-7560-4cd6-8309-2bbd5ca9b7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_29f1201e-3123-47e8-9cd7-64ff267d4381" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4f666670-7560-4cd6-8309-2bbd5ca9b7dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b1bb0d9f-a0d0-4820-8472-4c110929b2c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_823effda-63c5-4e70-82ee-88e9406ae731" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b1bb0d9f-a0d0-4820-8472-4c110929b2c2" xlink:to="loc_us-gaap_OperatingLeaseCost_823effda-63c5-4e70-82ee-88e9406ae731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_c0f48281-ce11-4b20-8f64-be2a5cdc8830" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b1bb0d9f-a0d0-4820-8472-4c110929b2c2" xlink:to="loc_us-gaap_ShortTermLeaseCost_c0f48281-ce11-4b20-8f64-be2a5cdc8830" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_052c3591-db04-469b-b9f9-ea8f71ea5e20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b1bb0d9f-a0d0-4820-8472-4c110929b2c2" xlink:to="loc_us-gaap_VariableLeaseCost_052c3591-db04-469b-b9f9-ea8f71ea5e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_23298d95-168b-4730-9268-92c267249ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b1bb0d9f-a0d0-4820-8472-4c110929b2c2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_23298d95-168b-4730-9268-92c267249ee6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_83061861-4a1c-4e76-b303-eeec6ab2e60a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_83061861-4a1c-4e76-b303-eeec6ab2e60a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cdae3da4-5997-4e91-b499-43bf4188c50d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_cdae3da4-5997-4e91-b499-43bf4188c50d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6eba1806-27a3-4ad3-8162-d57f9f7afd47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6eba1806-27a3-4ad3-8162-d57f9f7afd47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a20f421d-ffb1-4a1b-83ad-85669b86c689" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a20f421d-ffb1-4a1b-83ad-85669b86c689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b1b04640-c1dd-4df9-9d11-678bedb2f7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b1b04640-c1dd-4df9-9d11-678bedb2f7bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_9c5ee23e-4079-4e6b-918d-bf882b7c2a23" xlink:href="wst-20250331.xsd#wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f6f8d163-d45f-4499-bba9-3979cf40f8b5" xlink:to="loc_wst_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_9c5ee23e-4079-4e6b-918d-bf882b7c2a23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_652649f5-7858-4b70-8271-036d7867be06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_652649f5-7858-4b70-8271-036d7867be06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f6404f50-1e7b-4cdd-a14d-e0016557909a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f6404f50-1e7b-4cdd-a14d-e0016557909a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_304f2ea3-b764-4eab-acd0-f7c810844d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_304f2ea3-b764-4eab-acd0-f7c810844d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_0141ce52-9868-437e-884d-b1e3033ded19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_0141ce52-9868-437e-884d-b1e3033ded19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a2a2cb84-5353-4be8-b1ca-5d1c46c157ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_a2a2cb84-5353-4be8-b1ca-5d1c46c157ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_c14403cc-e528-47a7-8da6-8c3d9128779d" xlink:href="wst-20250331.xsd#wst_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_985e4c80-c530-44d3-9af3-bdf615ebc3ae" xlink:to="loc_wst_FinanceLeaseLiabilityToBePaidAfterYearFour_c14403cc-e528-47a7-8da6-8c3d9128779d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="wst-20250331.xsd#LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/LeasesMaturitiesofOperatingandFinanceLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1b937dd1-5668-4ced-8022-7d0ff51c253b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f04411d3-3b76-466c-872f-49c750d289a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1b937dd1-5668-4ced-8022-7d0ff51c253b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f04411d3-3b76-466c-872f-49c750d289a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d5941013-5a19-49bf-8002-9bcb627bf3f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1b937dd1-5668-4ced-8022-7d0ff51c253b" xlink:to="loc_us-gaap_FinanceLeaseLiability_d5941013-5a19-49bf-8002-9bcb627bf3f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86de225b-e1b0-480d-bd5b-a9d9110c1b18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5b484550-962c-46a3-a51b-9fce768c1106" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86de225b-e1b0-480d-bd5b-a9d9110c1b18" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5b484550-962c-46a3-a51b-9fce768c1106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_69928e25-7563-49aa-b7ab-18fa790fa9ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_86de225b-e1b0-480d-bd5b-a9d9110c1b18" xlink:to="loc_us-gaap_OperatingLeaseLiability_69928e25-7563-49aa-b7ab-18fa790fa9ef" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#DebtLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e1a02e4c-3be1-4e03-9f6d-10ae4184437e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_69cfda1d-b45d-46ed-a167-4b34e7dfb614" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e1a02e4c-3be1-4e03-9f6d-10ae4184437e" xlink:to="loc_us-gaap_LongTermDebtCurrent_69cfda1d-b45d-46ed-a167-4b34e7dfb614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3d8fa73e-cb19-47df-aab2-7a4f5066c7c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_e1a02e4c-3be1-4e03-9f6d-10ae4184437e" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3d8fa73e-cb19-47df-aab2-7a4f5066c7c4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DebtLongtermDebtDetails_1" xlink:type="simple" xlink:href="wst-20250331.xsd#DebtLongtermDebtDetails_1"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DebtLongtermDebtDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_48cf28a4-acf0-4963-96be-d1ea0f22b0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_1de98e62-dc13-4290-bd1e-eba777dc910e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_48cf28a4-acf0-4963-96be-d1ea0f22b0f2" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_1de98e62-dc13-4290-bd1e-eba777dc910e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_12e3bbac-46ac-4d5a-8dc9-1575d30e8804" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_48cf28a4-acf0-4963-96be-d1ea0f22b0f2" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_12e3bbac-46ac-4d5a-8dc9-1575d30e8804" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/DerivativeFinancialInstrumentsEffectsofDerivativeInstrumentsonOCIandEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_05c1cbeb-c462-4945-8986-50d56973dc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_8839ffe9-cec4-4f59-8019-bdda8934729a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_05c1cbeb-c462-4945-8986-50d56973dc0f" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_8839ffe9-cec4-4f59-8019-bdda8934729a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_24bd0f78-9148-4eef-926b-93b8d539a618" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_05c1cbeb-c462-4945-8986-50d56973dc0f" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1_24bd0f78-9148-4eef-926b-93b8d539a618" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_49f73d19-fcb9-4e03-bad2-d992cca5a1be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_05c1cbeb-c462-4945-8986-50d56973dc0f" xlink:to="loc_us-gaap_GainLossFromComponentsExcludedFromAssessmentOfFairValueHedgeEffectivenessNet_49f73d19-fcb9-4e03-bad2-d992cca5a1be" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/FairValueMeasurementsAssetsandLiabilitiesRecordedatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_49315172-e382-4343-acbc-b195df4c480e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationPlanAssets_2a12cc19-39de-43b9-a7bf-c0ba691bc5e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_49315172-e382-4343-acbc-b195df4c480e" xlink:to="loc_us-gaap_DeferredCompensationPlanAssets_2a12cc19-39de-43b9-a7bf-c0ba691bc5e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_4d367c93-5748-439a-8db7-5124c3a8dd90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractAssetFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_49315172-e382-4343-acbc-b195df4c480e" xlink:to="loc_us-gaap_ForeignCurrencyContractAssetFairValueDisclosure_4d367c93-5748-439a-8db7-5124c3a8dd90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_2025057e-a327-4732-8075-b0897024dd72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_49315172-e382-4343-acbc-b195df4c480e" xlink:to="loc_us-gaap_DerivativeAssets_2025057e-a327-4732-8075-b0897024dd72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_87480578-251c-4a18-ba6f-2e931bbca381" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_49315172-e382-4343-acbc-b195df4c480e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_87480578-251c-4a18-ba6f-2e931bbca381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_b949ab1b-0301-4044-a280-4950d017dbd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_823a9060-da0e-487a-94cc-bb2a3de598a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b949ab1b-0301-4044-a280-4950d017dbd9" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_823a9060-da0e-487a-94cc-bb2a3de598a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_0961717d-2b73-4150-bd5e-8b45bd436cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b949ab1b-0301-4044-a280-4950d017dbd9" xlink:to="loc_us-gaap_OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent_0961717d-2b73-4150-bd5e-8b45bd436cb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_8763500a-2903-4e8a-a2e9-26387fd3d67b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_b949ab1b-0301-4044-a280-4950d017dbd9" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_8763500a-2903-4e8a-a2e9-26387fd3d67b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/AccumulatedOtherComprehensiveLossComponentsofAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4c3ec890-3276-4216-97e5-c165dd653e79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_7275e84d-2ee0-40a9-8168-779b237ddb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4c3ec890-3276-4216-97e5-c165dd653e79" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_7275e84d-2ee0-40a9-8168-779b237ddb2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1a8a810e-2edd-40b9-a321-53e9e429ca6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4c3ec890-3276-4216-97e5-c165dd653e79" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_1a8a810e-2edd-40b9-a321-53e9e429ca6b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/OtherExpenseIncomeScheduleofOtherExpenseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_wst_OtherIncomeExpense_eca07135-4232-4b91-a92e-91743c186458" xlink:href="wst-20250331.xsd#wst_OtherIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_300660b4-200a-47e0-8c85-7521421c824d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostIncurredCost"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eca07135-4232-4b91-a92e-91743c186458" xlink:to="loc_us-gaap_RestructuringAndRelatedCostIncurredCost_300660b4-200a-47e0-8c85-7521421c824d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e97d4b5-29e6-4ef5-a937-e983cd751231" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eca07135-4232-4b91-a92e-91743c186458" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_8e97d4b5-29e6-4ef5-a937-e983cd751231" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_16bcfe89-d9a5-44a4-8a94-9cfb47cb5dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eca07135-4232-4b91-a92e-91743c186458" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_16bcfe89-d9a5-44a4-8a94-9cfb47cb5dd7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_3decf106-341a-4443-8e38-15f05c2d6abb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eca07135-4232-4b91-a92e-91743c186458" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_3decf106-341a-4443-8e38-15f05c2d6abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_de29324b-b280-4cfa-8e8d-0f0dce7d86e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_wst_OtherIncomeExpense_eca07135-4232-4b91-a92e-91743c186458" xlink:to="loc_us-gaap_AssetImpairmentCharges_de29324b-b280-4cfa-8e8d-0f0dce7d86e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="wst-20250331.xsd#SegmentInformationSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.westpharma.com/role/SegmentInformationSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_df4f4060-31e0-4970-a278-c24a69897bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a85f0ce0-06b2-46e6-a8c7-6149dfd5a847" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_df4f4060-31e0-4970-a278-c24a69897bfd" xlink:to="loc_us-gaap_OperatingIncomeLoss_a85f0ce0-06b2-46e6-a8c7-6149dfd5a847" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_wst_InterestIncomeExpenseAndOtherNonoperatingExpenseIncomeNet_c9a3b1ff-7728-4a3b-9791-916bedd39af7" xlink:href="wst-20250331.xsd#wst_InterestIncomeExpenseAndOtherNonoperatingExpenseIncomeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_df4f4060-31e0-4970-a278-c24a69897bfd" xlink:to="loc_wst_InterestIncomeExpenseAndOtherNonoperatingExpenseIncomeNet_c9a3b1ff-7728-4a3b-9791-916bedd39af7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a8edfab4-57c7-40e1-9312-b438ec9cfa1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b166a344-b663-4269-8080-7a88eb49becd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a8edfab4-57c7-40e1-9312-b438ec9cfa1d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b166a344-b663-4269-8080-7a88eb49becd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_c630281f-75a2-4222-a155-03b451ff4cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a8edfab4-57c7-40e1-9312-b438ec9cfa1d" xlink:to="loc_us-gaap_RestructuringCharges_c630281f-75a2-4222-a155-03b451ff4cb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9750e1f6-6cd6-455e-b02b-111e3225909a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a8edfab4-57c7-40e1-9312-b438ec9cfa1d" xlink:to="loc_us-gaap_ShareBasedCompensation_9750e1f6-6cd6-455e-b02b-111e3225909a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_24642f36-dca6-4e37-8b73-869759911668" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_a8edfab4-57c7-40e1-9312-b438ec9cfa1d" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_24642f36-dca6-4e37-8b73-869759911668" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
